Published in J Thromb Haemost on May 01, 2006
Inflammatory concepts of obesity. Int J Inflam (2011) 1.14
Nonalcoholic fatty liver disease and measures of early brain health in middle-aged adults: The CARDIA study. Obesity (Silver Spring) (2017) 0.75
Effect of sibutramine on weight maintenance after weight loss: a randomised trial. STORM Study Group. Sibutramine Trial of Obesity Reduction and Maintenance. Lancet (2001) 3.60
Environmental pollutants and type 2 diabetes: a review of mechanisms that can disrupt beta cell function. Diabetologia (2011) 1.85
Overweight, obesity, and blood pressure: the effects of modest weight reduction. Obes Res (2000) 1.78
Reduction of the plasma concentration of C-reactive protein following nine months of endurance training. Int J Sports Med (2000) 1.60
Human leptin: from an adipocyte hormone to an endocrine mediator. Eur J Endocrinol (2000) 1.53
Obesity, haemostasis and the fibrinolytic system. Obes Rev (2002) 1.40
The senile lung. Comparison with normal and emphysematous lungs. 1. Structural aspects. Chest (1992) 1.27
Among inflammation and coagulation markers, PAI-1 is a true component of the metabolic syndrome. Int J Obes (Lond) (2006) 1.22
Maintained intentional weight loss reduces cardiovascular outcomes: results from the Sibutramine Cardiovascular OUTcomes (SCOUT) trial. Diabetes Obes Metab (2012) 1.19
Evaluation of cerebral vasomotor reactivity by various vasodilating stimuli: comparison of CO2 to acetazolamide. J Cereb Blood Flow Metab (1992) 1.12
Leptin levels in type 2 diabetes: associations with measures of insulin resistance and insulin secretion. Horm Metab Res (2003) 1.06
Total respiratory resistance and reactance in patients with diffuse interstitial lung disease. Eur Respir J (1989) 1.06
Addition of rosiglitazone to metformin is most effective in obese, insulin-resistant patients with type 2 diabetes. Diabetes Obes Metab (2003) 1.04
Bacteraemia with Leptotrichia buccalis: report of a case and review of the literature. Acta Clin Belg (1996) 1.00
The senile lung. Comparison with normal and emphysematous lungs. 2. Functional aspects. Chest (1992) 1.00
Polymorphisms in the leptin receptor gene, body composition and fat distribution in overweight and obese women. Int J Obes Relat Metab Disord (2001) 1.00
High prevalence of manifestations of gastric autoimmunity in parietal cell antibody-positive type 1 (insulin-dependent) diabetic patients. The Belgian Diabetes Registry. J Clin Endocrinol Metab (1999) 0.98
Leptin receptor gene polymorphisms are associated with insulin in obese women with impaired glucose tolerance. J Clin Endocrinol Metab (2001) 0.96
[Liraglutide (Victoza): human glucagon-like peptide-1 used in once daily injection for the treatment of type 2 diabetes]. Rev Med Liege (2010) 0.95
Visceral adiposity and insulin resistance are independent predictors of the presence of non-cirrhotic NAFLD-related portal hypertension. Int J Obes (Lond) (2010) 0.95
Visceral adipose tissue and inflammation correlate with elevated liver tests in a cohort of overweight and obese patients. Int J Obes (Lond) (2010) 0.94
Initiating oral glucose-lowering therapy with metformin in type 2 diabetic patients: an evidence-based strategy to reduce the burden of late-developing diabetes complications. Diabetes Metab (2004) 0.92
Diabetic ketoacidosis-induced hyperkalemia. Prevalence and possible origin. Intensive Care Med (1986) 0.90
Hemoperfusion-hemodialysis ineffective for paraquat removal in life-threatening poisoning? J Toxicol Clin Toxicol (1985) 0.89
Helicobacter pylori, parietal cell antibodies and autoimmune gastropathy in type 1 diabetes mellitus. Aliment Pharmacol Ther (2002) 0.87
Anthropometric and calorimetric evidence for the protein sparing effects of a new protein supplemented low calorie preparation. Am J Clin Nutr (1985) 0.84
Gastric parietal cell antibodies are associated with glutamic acid decarboxylase-65 antibodies and the HLA DQA1*0501-DQB1*0301 haplotype in Type 1 diabetes mellitus. Belgian Diabetes Registry. Diabet Med (2000) 0.83
Genetic association between WNT10B polymorphisms and obesity in a Belgian case-control population is restricted to males. Mol Genet Metab (2011) 0.83
Mutational and genetic origin of LDL receptor gene mutations detected in both Belgian and Dutch familial hypercholesterolemics. Hum Genet (1997) 0.82
Tissue and airway impedance of excised normal, senile, and emphysematous lungs. J Appl Physiol (1985) (1992) 0.81
Modern, new pharmacotherapy for obesity. A gastrointestinal approach. Best Pract Res Clin Gastroenterol (2004) 0.80
Serum and erythrocyte magnesium levels in type I and type II diabetics. Acta Diabetol Lat (1986) 0.79
Dose-response of simvastatin in primary hypercholesterolemia. J Cardiovasc Pharmacol (1994) 0.78
Are leptin levels dependent on body fat distribution in obese men and women? Eat Weight Disord (1998) 0.78
Soluble transferrin receptor level: a new marker of iron deficiency anemia, a common manifestation of gastric autoimmunity in type 1 diabetes. Diabetes Care (2000) 0.78
[Medication of the month... Exenatide (Byetta) incretinomimetic in the treatment of type 2 diabetes after failure and as add-on therapy to oral agents]. Rev Med Liege (2008) 0.78
[Linagliptin (Trajenta): a selective DPP-4 inhibitor with limited renal elimination]. Rev Med Liege (2012) 0.77
Elevated plasminogen activator inhibitor levels in cyclosporin-treated renal allograft recipients. Nephrol Dial Transplant (1996) 0.77
Screening for melanocortin-4 receptor mutations in a cohort of Belgian morbidly obese adults and children. Int J Obes (Lond) (2006) 0.77
Screening for genetic variants in BDNF that contribute to childhood obesity. Pediatr Obes (2013) 0.76
[Cardiometabolic effects of rimonabant in obese/overweight subjects with dyslipidaemia or type 2 diabetes]. Rev Med Liege (2007) 0.76
Metabolic disregulation in obese adolescents with sleep-disordered breathing before and after weight loss. Obesity (Silver Spring) (2013) 0.76
Two novel frameshift mutations in the low density lipoprotein receptor gene generated by endogenous sequence-directed mechanisms. Hum Genet (1995) 0.76
[Sugar: results of a Belgian observational study on the use of sitagliptin in patients with type 2 diabetes]. Rev Med Liege (2010) 0.76
[Endocannabinoid system in the brain...and elsewhere]. Rev Med Liege (2008) 0.75
Body fat, body fat distribution and the respiratory system: a "fat neck" syndrome? Eur Respir J (1992) 0.75
Carbohydrate-induced thermogenesis in obese women. Effect of insulin and catecholamines. J Endocrinol Invest (1999) 0.75
Balance of glutamate and dopamine in the nucleus accumbens modulates self-stimulation behavior after injection of cholecystokinin and neurotensin in the rat brain. Peptides (1992) 0.75
[Medication of the month. Rimonabant (Acomplia): first CB1 receptor antagonist of the endocannabinoid system]. Rev Med Liege (2008) 0.75
Autoimmune hepatitis, autoimmune gastritis, and gastric carcinoid in a type 1 diabetic patient: a case report. J Diabetes Complications (2000) 0.75
[Improved glucose control and weight loss with exenatide in patients with type 2 diabetes: results of a retrospective observational multicentre Belgian study]. Rev Med Liege (2009) 0.75
[Sitagliptine (Januvia): incretin enhancer potentiating insulin secretion for the treatment of type 2 diabetes]. Rev Med Liege (2008) 0.75
A case of malnutrition after biliopancreatic diversion for morbid obesity. Int J Obes Relat Metab Disord (1993) 0.75
Is there an increased incidence of surgically removed thyroid carcinoma in Belgium ten years after Chernobyl? A study of hospital discharge data. Acta Chir Belg (2008) 0.75
A silver impregnation utilizing only reagent-grade chemicals for visualization of peripheral axons and fibroblasts. J Microsc (1998) 0.75
[Sitagliptin in the treatment of type 2 diabetes: insights five years after commercialisation]. Rev Med Liege (2013) 0.75
Insulinotropic effect of different formula of very low calorie protein supplemented diets in obesity. Acta Clin Belg (1987) 0.75
Promising new approaches to the management of obesity. Drugs (2000) 0.75
Perioperative parenteral nutrition in the stressed diabetic patient. World J Surg (1986) 0.75
Common genetic variation in sFRP5 is associated with fat distribution in men. Endocrine (2013) 0.75
Decreased diet-induced thermogenesis in gluteal-femoral obesity. J Am Coll Nutr (1989) 0.75
[The cost of type 2 diabetes: summary of the Cost of Diabetes in Europe-Type II study (CODE-2) and analysis of the situation in Belgium]. Rev Med Liege (2005) 0.75
Sclerotic IgA myeloma and polyneuropathy: the POEMS syndrome. Case report. Ann Oncol (1995) 0.75
Effects of smoking on lipid parameters during therapeutic weight loss. Atherosclerosis (1986) 0.75
A rare silent G to T mutation in exon 4 of the human low density lipoprotein receptor gene. Clin Genet (1995) 0.75
No conclusive evidence for association of polymorphisms in the adiponectin receptor 1 gene, AdipoR1, with common obesity. Endocrine (2012) 0.75
Phenotypic expression and frequency of familial defective apolipoprotein B-100 in Belgian hypercholesterolemics. Atherosclerosis (1994) 0.75
[Jentadueto, fixed combination of linagliptin plus metformin for the treatment of type 2 diabetes]. Rev Med Liege (2013) 0.75
[Clinical study of the month. Accord-lipid and accord-eye: towards a new positioning of fenofibrate in the management of type 2 diabetes]. Rev Med Liege (2010) 0.75
[Type 2 diabetes, in the heart of the metabolic syndrome: plea for a global approach]. Rev Med Liege (2005) 0.75
[Glycemic control before and after sitagliptin in general medical practice: analysis of determinant factors in the Belgian observational study "SUGAR"]. Rev Med Liege (2011) 0.75
Intronic mutations at splice junctions in the low-density lipoprotein receptor gene. Mol Cell Probes (1999) 0.75
Influence of mebendazole administration on metabolic control in type 1 (insulin-dependent) diabetic patients. Diabetologia (1985) 0.75
Preparation and certification of a reference material on PCBs in pig fat and its application in quality control in monitoring laboratories during the Belgian "PCB-crisis". Chemosphere (2001) 0.75
The "endocrine" dysmetabolism of visceral obesity. Lessons from exercise research. Eur J Med (1993) 0.75